Masahiro Shimomura

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Effects of Intestinal and Hepatic Metabolism on the Bioavailability of Tacrolimus in Rats

Yukiya Hashimoto, Hiroaki Sasa, Masahiro Shimomura et al. · Pharmaceutical Research · 1998 · 70 citations

Roles of the Jejunum and Ileum in the First-Pass Effect as Absorptive Barriers for Orally Administered Tacrolimus

Masahiro Shimomura, Satohiro Masuda, Hideyuki Saito et al. · Journal of Surgical Research · 2002 · 43 citations

First-pass Effect, Orally Administered Tacrolimus, Gastrointestinal Pharmacology +6

Transient up-regulation of P-glycoprotein reduces tacrolimus absorption after ischemia–reperfusion injury in rat ileum

Takanori Omae, Maki Goto, Masahiro Shimomura et al. · Biochemical Pharmacology · 2004 · 27 citations

Inflammation, Molecular Pharmacology, Ischemia–reperfusion Injury +8

TBX2 expression is associated with platinum‑sensitivity of ovarian serous carcinoma

Reiko Tasaka, Takeshi Fukuda, Masahiro Shimomura et al. · Oncology Letters · 2017 · 19 citations · Full text